In light of these findings, Gilead has forwarded the compound to China to allow for a number of trials on individuals infected with SARS-CoV-2, and the results are highly anticipated.
Kwa misingi hii, Gilead imetoa dawa hiyo kwa China ili iendeshe jozi ya majaribio kwa watu walioambukizwa SARS-CoV-2 na matukio yanatarajiwa sana.